High-valence bismuth(V) nanoplatform to potentiating tumor immunotherapy
A high-valence bismuth(V) nanoplatform has been proposed for the first time for triggering cancer cell death and anti-tumor immune responses via an exogenous excitation-free and endogenous H2O2- and O2-independent reactive oxygen species generation behavior.